Design, prototyping and validation

Make your innovations real

MedTech companies face intense pressure to innovate while operating in one of the world’s most regulated and risk‑averse environments. Teams need to accelerate development without compromising safety, explore new ideas without creating regulatory or manufacturing headaches, and ensure devices succeed beyond the lab, in the real world. Too often, products that look strong in concept stall during validation, or prove too complex or costly to scale, undermining long‑term revenue.

How can MedTech companies overcome these new challenges and drive more products successfully to market? The solution lies in a cohesive end-to-end process.

Turning design into business value

Design, prototyping, and validation are not about aesthetics or engineering excellence alone. They are about making the right decisions early to ensure that products stand up to regulatory scrutiny, scale efficiently, and succeed in the market. Multiple elements go into design, including human needs, technical feasibility, regulatory requirements, and commercial realities. By addressing these factors together, design becomes a direct driver of successful product performance. Capgemini’s world-leading design team, frog, sets up your innovation for success from day one.

Starting off with a strong design improves every step along the pipeline, from testing to manufacturability to scalability. By testing assumptions thoroughly early in the process, we help surface risks before they become problems. Validation is not treated as a final hurdle, but as a source of insight throughout the journey, ensuring devices are ready for real clinical environments.

Client stories

Electrogenics Labs improves patient care in radiation therapy with MOSkin™

Capgemini supports the development of the MOSkin™ integrated system to ensure accurate radiation dose verification

Read more

End‑to‑end by design

Design is just the beginning. Capgemini brings deep, integrated expertise that spans the entire process of bringing a MedTech product to market. This includes:

  • human‑centered design
  • systems engineering
  • rapid and physical prototyping
  • verification and validation
  • regulatory insight
  • manufacturing readiness
  • security by design (from chip to cloud)

– all combined into one continuous, end-to-end process. This integrated production environment gives your vision the best chance to develop into a life-changing product. It’s the process that makes your vision real – efficiently, and without costly surprises.

Adding value at every step

We’ve all seen it happen. A brilliant idea enters the development process – something with the potential to be truly great. But as it moves down the line, one feature after another is subjected to compromise. Too expensive. Hard to manufacture. Regulator issues. The product gets worn down at every stage until it finally launches as a mediocre, forgettable product.

A properly managed pipeline adds value at every step. Products are designed with the full process in mind, eliminating costly surprises. Shared digital ecosystems make each component more valuable. From early concepts and tangible prototypes through validation and launch readiness, we help MedTech innovators deliver products that clinicians want to use, regulators trust, and manufacturers can scale. Not only fast to launch, but built to last.

We’re here to make your vision real. Let’s get to work on the kind of medical products that change patients’ lives.

Meet our experts

James Luther

James Luther

MedTech Leader, Frog
As the MedTech lead based in Milan, James helps leading healthcare and medical device organizations define and deliver user-centered products, digital experiences, and services. He brings over 35 years of experience as an award winning product designer and researcher, working across the full lifecycle from insight generation to product realization. He has spent thousands of hours embedded in patient homes, surgeries, clinics, and hospitals across Europe, Asia, and the Americas, translating real-world user needs into impactful, innovative solutions.
Chiara Diana

Chiara Diana

Chief Design Officer, frog, part of Capgemini Invent
As our Experience expert, Chiara helps clients elevate and refine their CX strategy and execution by unifying brand, strategy and delivery into a holistic experience framework that strengthens loyalty and relationships with customers and employees..
Gemma Holbrow

Gemma Holbrow

Head of Healthcare at Cambridge Consultants
Gemma Holbrow leads Cambridge Consultants’ Healthcare business within Capgemini, driving innovation across drug delivery, life sciences, diagnostics, and medical devices. She works with global clients to transform deep tech innovation into impactful, market ready MedTech solutions that transform businesses and improve patient outcomes worldwide.
Kaethe Henning

Kaethe Henning 

Director, Consumer HealthTech Business
Kaethe is a Director in Capgemini Invent’s Consumer HealthTech practice and part of the Synapse Product Development team. She brings deep experience in connected health and medical device development, partnering with venture-backed startups and established innovators to bring regulated and non-regulated products from concept through commercialization. Kaethe specializes in bridging user-centered design, engineering, and clinical realities to deliver differentiated, scalable medical device technologies.
Mark Huss

Mark Huss

AVP, Life Sciences Lead, Sogeti part of Capgemini
Mark leads Life Sciences for the Sogeti (mid-market) part of Capgemini. He has worked globally within the Life Sciences and Healthcare sectors for the last 30+ years. He has led product design and engineering, architecture, software, data and AI functions. He is passionate about helping companies and people that create products that improve people’s lives. Nothing gives him more pleasure than seeing a product and company succeed, and he would love to help yours do the same.

    FAQ

    Capgemini sees design and prototyping as direct drivers of success. Early design decisions influence usability, cost, regulatory success, and long‑term market performance.

    MedTech companies often struggle to balance speed, safety, regulatory compliance, and manufacturability. Capgemini frequently sees promising concepts fail during validation or struggle to scale because downstream constraints were not addressed early enough.

    Capgemini approaches design as a business discipline, grounded in real‑world use, technical feasibility, and regulatory reality. Human needs, engineering constraints, and commercial goals are considered together from the start.

    Capgemini emphasizes end‑to‑end execution because disconnected phases increase risk and rework. When design, prototyping, testing, validation, and manufacturing readiness are aligned, products move faster to market with fewer surprises.

    Capgemini integrates manufacturability, cost, and scalability considerations into the design process from the outset. This helps MedTech companies avoid redesigns and supports efficient production and long‑term growth.

    Capgemini places strong emphasis on understanding clinicians, patients, and care environments. Designing around real workflows and needs improves usability, trust, and adoption – key factors in long‑term commercial success.